✦ LIBER ✦

Dose-Intense BEACOPP May Be Effective in Patients with Poor Prognostic Hodgkin's Disease

Book ID: 119615173
Publisher: CIG Media Group, LP.
Year: 2000
Tongue: English
Weight: 71 KB
Volume: 1
Category: Article
ISSN: 1526-9655
DOI: 10.1016/s1526-9655(11)70216-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9231 POSTER BEACOPP-14 Vs. BEACOPP-esc i

9231 POSTER BEACOPP-14 Vs. BEACOPP-esc in Patients With Hodgkin's Disease From Poor-prognosis Group – Updated Results of Prospective Randomized Multicenter Study

✍ Titorenko, I.; Kriachok, I.; Filonenko, K.; Novosad, O.; Alexik, O.; Kadnikova, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Non-melanoma skin cancer may be a marker

Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma

✍ Henrik Hjalgrim; Morten Frisch; Hans H. Storm; Bengt Glimelius; Jakob Bøje Peder 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 2 views

According to recent results, patients with non-melanoma skin cancers are at increased risk of developing non-Hodgkin's lymphoma (NHL). The prognostic significance of this association is unknown. Two cohorts of patients with a first diagnosis of non-melanoma skin cancer and a subsequent diagnosis of

Topical tacrolimus may be effective in p

Topical tacrolimus may be effective in paediatric patients with severe treatment-resistant Crohn's disease

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

A numerical prognostic index for clinica

A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis

✍ Proctor, Stephen J; Taylor, Penny; Donnan, Peter; Boys, Richard; Lennard, Anne; 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 761 KB

Rivastigmine may be effective in the tre

Rivastigmine may be effective in the treatment of patients with Alzheimer's disease who have vascular risk factors

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

A prospective study of intensive inducti

A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin’s lymphoma and two or three adverse prognostic factors

✍ Dumontet, C; Thieblemont, C; Espinouse, D; Bouafia, F; Hequet, O; Salles, G; Coi 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB